BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37466573)

  • 1. Risk Factors for All-Cause Early Reoperation Following Tumor Resection and Endoprosthetic Reconstruction: A Secondary Analysis from the PARITY Trial.
    Kendal JK; Slawaska-Eng D; Gazendam A; Schneider P; Wessel LE; Ghert M; Bernthal NM;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):4-9. PubMed ID: 37466573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Implant Fixation Type on Reoperation Rates Following Endoprosthetic Reconstruction Surgery.
    Giglio V; Gazendam A; Schneider P; Ghert M; Wilson D;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):15-21. PubMed ID: 37466575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Operative Treatment and Outcomes of Pediatric Patients with an Extremity Bone Tumor: A Secondary Analysis of the PARITY Trial Data.
    Bozzo A; Yeung CM; Van De Sande M; Ghert M; Healey JH;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):65-72. PubMed ID: 37466582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proximal Tibia Reconstruction After Bone Tumor Resection: Are Survivorship and Outcomes of Endoprosthetic Replacement and Osteoarticular Allograft Similar?
    Albergo JI; Gaston CL; Aponte-Tinao LA; Ayerza MA; Muscolo DL; Farfalli GL; Jeys LM; Carter SR; Tillman RM; Abudu AT; Grimer RJ
    Clin Orthop Relat Res; 2017 Mar; 475(3):676-682. PubMed ID: 27103142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and Surgical Risk Factors for Surgical Site Infection in Lower-Extremity Oncological Endoprosthetic Reconstruction: A Secondary Analysis of the PARITY Trial Data.
    Slawaska-Eng D; Gazendam AM; Kendal J; Schneider P; Becker RG; Freitas JP; Bernthal N; Ghert M;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):41-48. PubMed ID: 37466579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Causes and Frequencies of Reoperations After Endoprosthetic Reconstructions for Extremity Tumor Surgery: A Systematic Review.
    Thornley P; Vicente M; MacDonald A; Evaniew N; Ghert M; Velez R
    Clin Orthop Relat Res; 2019 Apr; 477(4):894-902. PubMed ID: 30801278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are Pasteurized Autografts Durable for Reconstructions After Bone Tumor Resections?
    Lee SY; Jeon DG; Cho WH; Song WS; Kim BS
    Clin Orthop Relat Res; 2018 Sep; 476(9):1728-1737. PubMed ID: 30794210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Duration Is Independently Associated with an Increased Risk of Surgical Site Infection and May Not Be Mitigated by Prolonged Antibiotics: A Secondary Analysis of the PARITY Trial of Infection After Lower-Extremity Endoprosthetic Reconstruction for Bone Tumors.
    Zeitlinger L; Wilson M; Randall RL; Thorpe S;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):79-86. PubMed ID: 37466584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What Is the Implant Survivorship and Functional Outcome After Total Humeral Replacement in Patients with Primary Bone Tumors?
    Schneider KN; Bröking JN; Gosheger G; Lübben T; Hardes J; Schorn D; Smolle MA; Theil C; Andreou D
    Clin Orthop Relat Res; 2021 Aug; 479(8):1754-1764. PubMed ID: 33595237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical Site Infection Is Not Associated with 1-Year Progression-Free Survival After Endoprosthetic Reconstruction for Lower-Extremity Osteosarcoma: A Secondary Analysis of PARITY Study Data.
    Jackson KJ; Sullivan CD; Zimel MN; Wustrack RL;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):49-56. PubMed ID: 37466580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant Chemotherapy and Endoprosthetic Reconstruction for Lower Extremity Sarcomas: Does Timing Impact Complication Rates?
    Gazendam AM; Schneider P; Spiguel A; Ghert M
    Ann Surg Oncol; 2022 Nov; 29(12):7312-7317. PubMed ID: 35864365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic Antibiotic Regimens In Tumor Surgery (PARITY): a multi-center randomized controlled study comparing alternative antibiotic regimens in patients undergoing tumor resections with endoprosthetic replacements-a statistical analysis plan.
    Schneider P; Heels-Ansdell D; Thabane L; Ghert M;
    Trials; 2021 Mar; 22(1):223. PubMed ID: 33752752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of and Risk Factors for Thromboembolism After Endoprosthetic Reconstruction in Musculoskeletal Oncology Patients.
    Sabharwal S; LiBrizzi CL; Forsberg JA; Morris CD; Levin AS;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):29-33. PubMed ID: 37466577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LUMiC
    Bus MP; Szafranski A; Sellevold S; Goryn T; Jutte PC; Bramer JA; Fiocco M; Streitbürger A; Kotrych D; van de Sande MA; Dijkstra PD
    Clin Orthop Relat Res; 2017 Mar; 475(3):686-695. PubMed ID: 27020434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does the Use of Negative Pressure Wound Therapy and Postoperative Drains Impact the Development of Surgical Site Infections?: A PARITY Trial Secondary Analysis.
    LiBrizzi CL; Sabharwal S; Forsberg JA; Leddy L; Doung YC; Morris CD; Levin AS;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):34-40. PubMed ID: 37466578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric and Adult Patients Have Similar Functional Improvement After Endoprosthetic Reconstruction of Lower-Extremity Tumors.
    Tran TH; Hayden JB; Gazendam AM; Ghert M; Gundle KR; Doung YC;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):22-28. PubMed ID: 37466576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What Is the Survival of the Telescope Allograft Technique to Augment a Short Proximal Femur Segment in Children After Resection and Distal Femur Endoprosthesis Reconstruction for a Bone Sarcoma?
    Hindiskere S; Staals E; Donati DM; Manfrini M
    Clin Orthop Relat Res; 2021 Aug; 479(8):1780-1790. PubMed ID: 33635286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
    Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
    Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical Site Infection in Patients Managed with an Endoprosthesis for the Treatment of Cancer: Evaluation of Patient, Disease, and Index Surgical Factors.
    Ray GS; Werth P; Alexander JH; Eward WC; Bernthal NM; Jeys LM; Funovics P; Windhager R; Temple HT; Lozano-Calderon S; Avedian RS; Jutte PC; Ghert M; Ruggieri P; Henderson ER;
    J Bone Joint Surg Am; 2023 Jul; 105(Suppl 1):87-96. PubMed ID: 37466585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Functional Recovery among Musculoskeletal Oncology Patients Undergoing Lower Extremity Endoprosthetic Reconstruction.
    Gazendam AM; Schneider P; Heels-Ansdell D; Bhandari M; Busse JW; Ghert M
    Curr Oncol; 2022 Oct; 29(10):7598-7606. PubMed ID: 36290877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.